Cavernoscanner: Technique and modelling in erectile dysfunction due to caverno-venous leakage (CVL)

Main Article Content

Sussman H, MD Hauet P, MD Ordureau S Eric Allaire, MD, PhD Virag R


As a result of technical progress in the exploration of erectile dysfunction by caverno-venous leaks, initiated by conventional radiography under artificial erection, authenticated by ultrasound under pharmacological stimulation, cavernoscanner is proving to be an indispensable tool for their precise localization. The study of 337 consecutive examinations carried out over 5 years (2015-2020) with the Vizua platform made it possible to confirm the initial classification proposed by Virag and Paul, distinguishing between no leakage (A), deep leakage (B), superficial leakage (C), and the addition of deep and superficial leakage (D); and to identify two additional locations: opacification of the corpus spongiosum and leakage from the bottom of the corpora cavernosa. A total of 11.57% had no leakage, giving an efficiency of 88.3% for the orientation by pharmacologically stimulated ultrasound; 20.17% had a deep leakage, of which 10.9% were isolated; 15.3% had a superficial leakage, of which 5.4% were isolated; finally 46% had mixed leakage, of which 20.47% had no communication with the corpus spongiosum and leakage through the floor of the corpora cavernosa. CT scan was performed under pharmacological stimulation and contrast medium perfusion with 3 acquisition passages: filling, state phase and emptying. The study of the native and reconstructed images allows the systematized localizations, the evaluation of the severity of the leakage based on the rigidity obtained and the speed of evacuation with or without bladder opacification. Complications are minor (ecchymosis) and the very rare persistence of a rigid erection (n=3) well controlled by injection of the alpha-blocker etilefrine.

Keywords: cavernoscanner, CT scan, erectile dysfunction, caverno-venous leak,, penile ultrasonography, pharmacological stimulation of erection, intracavernous injection, erecion hardness score

Article Details

How to Cite
H, Sussman et al. Cavernoscanner: Technique and modelling in erectile dysfunction due to caverno-venous leakage (CVL). Medical Research Archives, [S.l.], v. 11, n. 1, jan. 2023. ISSN 2375-1924. Available at: <>. Date accessed: 21 july 2024. doi:
Research Articles


1-Virag R et al Intracavernous self injection of vasoactive drugs in the treatment of impotence: 8-year experience with 615 cases 1991; 145: 287-292

2- Sussman H et al Ultrasonography after pharmacological stimulation of erection for the diagnosis and therapeutic follow up of erectile dysfunction due to cavernovenous leakage J.Mal Vasc2020; 45: 3-12

3- Virag R., Paul JF. New Classification of Anomalous Venous Drainage Using Caverno-Computed To-mography in Men with Erectile Dysfunction. The Journal of Sexual Medicine, 2011; 8:1439-44.

4-Virag R., L'exploration multidisciplinaire de l'impuissance: résultats d'une etude préliminaire su 339 cas 1982 INIST PASCAL83X0181773

5- Ashdown R.R et al Impotence in bulls abnormal drainage of corpus cavernosum penis Vet Res 1979 ; 104 18-39

6-Goldstein I et al. The erection hardness score and its relationship to successful sexual intercourses. J Sex Med 2018; 5: 2374-80

7- Virag R, Perry Spencer P, Frydman D Artificial Erection in diagnosis and treatment of impotence. 1984; 28; 153-161

8-Virag R., Frydman D, Legman M, Intracavernous injection of papaverine as a diagnostic and thera-peutic method in erectile failure. Angiology 1984; 35: 79-87

9-Allaire E., Sussman H., Zugail A. et al. Erectile dysfunction resistant to medical treatment caused by cavernovenous leakage: an innovative surgical approach combining preoperative work up, embolization and open surgery. Eur J Vasc Endovasc Surg 2021 Mar ;61(3):510-517. ejvs.2020.08.048 Epub 2020 Oct 13

10-Joguet E Analysis of failures in surgical treatment of caverno-venous leaks. DU-TEC 2020-21 Sor-bonne Medicine University thesis

11 Hsu GL et al. Penile venous anatomy: an additional description and its clinical implication. Journal of Andrology 2013; 24: 921-927b